SCHEMBL30165272

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCCC(=O)O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	12/20	0.49

▸	CALCR	P30988	4/20	0.47

▸	CRHR1	P34998	1/20	0.46

▸	CRHR2	Q13324	1/20	0.46

▸	GRIN2D	O15399	1/20	0.46

▸	GRIN3B	O60391	1/20	0.46

▸	GRIN1	Q05586	1/20	0.46

▸	GRIN2A	Q12879	1/20	0.46

▸	GRIN2B	Q13224	1/20	0.46

▸	GRIN2C	Q14957	1/20	0.46

▸	GRIN3A	Q8TCU5	1/20	0.46

▸	F2	P00734	1/20	0.46

▸	KEAP1	Q14145	1/20	0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30165190	0.97	GLP1R (0.48)	GLP1RCALCRF2
SCHEMBL30165148	0.94	GRIN2D (0.48)	GLP1RCALCRCRHR1CRHR2GRIN2D
SCHEMBL30165255	0.94	GRIN2D (0.48)	GLP1RCALCRCRHR1CRHR2GRIN2D
SCHEMBL30165162	0.92	CTSD (0.46)	GLP1RCALCRCRHR1CRHR2GRIN2D
SCHEMBL30165147	0.92	F2 (0.48)	GLP1RGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30165207	0.92	F2 (0.48)	GLP1RGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30165209	0.92	GRIN2D (0.48)	GLP1RCALCRCRHR1CRHR2GRIN2D
SCHEMBL30165181	0.92	BACE1 (0.50)	GLP1RCALCR
SCHEMBL30165145	0.91	GLP1R (0.50)	GLP1RCALCRCRHR1CRHR2
SCHEMBL30165174	0.91	GLP1R (0.50)	GLP1RCALCRCRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2023006083-A1	NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF	英纳氏(珠海)药业有限公司	2023-02-02	—	—	WO	disclosed